lung disease

Advertisement
DocWire News EditorsATS 2021 Conference Coverage | May 14, 2021
After one year of treatment with the CFTR modulators elexacaftor-tezacaftor-ivacaftor, patients with cystic fibrosis ...
Read More
DocWire News EditorsCardiology | February 25, 2021
A new analysis suggests that long-term exposure to air pollution poses a significant risk to the heart and lung heath of ...
DocWire News EditorsFuture of Medicine | October 11, 2019
The Wake Forest Institute for Regenerative Medicine (WFIRM) has recently received a $24 million federal grant from the ...
Kerri FitzgeraldBreast Cancer News | March 26, 2025
The U.S. Food and Drug Administration (FDA) issued a warning that three breast cancer drugs, Ibrance® (palbociclib), ...
DocWire News EditorsFuture of Medicine | April 7, 2023
Recent research from Cedars-Sinai shows that a protein associated with cancer growth may play a role in developing ...
Kaitlyn D’OnofrioRheumatology | April 12, 2023
Patients with diffuse cutaneous systemic sclerosis (SSc) who experience progressive skin fibrosis may be at an increased ...
Kaitlyn D’OnofrioPulmonology | April 10, 2023
The National Institute for Health and Care Excellence (NICE) has shared new guidelines pertaining to the diagnosis and ...
Kaitlyn D’OnofrioDementia | April 12, 2023
Midlife lung disease and impaired lung function may be associated with dementia and cognitive impairment later in life, ...
Kaitlyn D’OnofrioPulmonology | April 10, 2023
The U.S. Food and Drug Administration (FDA) has approved a new drug, Arikayce (amikacin liposome inhalation ...
Kaitlyn D’OnofrioAI | April 12, 2023
A deep learning algorithm more accurately diagnosed fibrotic lung diseases than a team of specialist thoracic ...
Advertisement
Advertisement
Latest News

April 25, 2025